Search | IOVS | ARVO Journals

Showing 1 – 20 of 85

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

Retina April 2019

Dark-Adapted Two-Color Fundus-Controlled Perimetry in Macular Telangiectasia Type 2

PDF

Tjebo F. C. Heeren; Simone Tzaridis; Roberto Bonelli; Maximilian Pfau; Marcus Fruttiger; Mali Okada; Catherine Egan; Peter Charbel Issa; Frank G. Holz
TAGS: color, perimetry, rod photoreceptors, telangiectasis, eye
Invest. Ophthalmol. Vis. Sci.. 2019; 60(5):1760-1767. doi: 10.1167/iovs.18-25360

ARVO Annual Meeting Abstract July 2018

Diabetes mellitus in MacTel Can Diabetes Mellitus be a negative prognosticator in MacTel?

Daniela Florea; Tatiana Mansour; Traci Clemons; Konstantinos Balaskas; Catherine Egan; Tunde Peto

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1034. doi:

ARVO Annual Meeting Abstract July 2018

Longitudinal Assessment Of Reading Test Performance In Patients With Type 2 Macular Telangiectasia (MacTel)

Simona Degli Esposti; Sarah Sirrell; Tjebo FC Heeren; Catherine Egan; Gary S Rubin

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1262. doi:

ARVO Annual Meeting Abstract July 2018

Twelve-month longitudinal study of remnant cone structure in macular telangiectasia type 2

Mali Okada; Katie M Litts; Tjebo FC Heeren; Angelos Kalitzeos; Vincent Rocco; Rebecca Mastey; Navjit Singh; Thomas Kane; Melissa Kasilian; Michel Michaelides; Marcus Fruttiger; Joseph Carroll; Catherine Egan

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):4628. doi:

ARVO Annual Meeting Abstract July 2018

Macular photoreceptor atrophy defines the end stage of macular telangiectasia type 2

Tjebo FC Heeren; Traci E Clemons; Marcus Fruttiger; Catherine Egan; Peter Charbel Issa

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3138. doi:

ARVO Annual Meeting Abstract July 2018

Human Serum Metabolomics Study in Macular Telangiectasia Type 2

Sasha Woods; Michael Powner; Senthil Selvam; Kamron Khan; Robyn H Guymer; Jennifer Trombley; Catherine Egan; Martin Friedlander; Marcus Fruttiger

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3154. doi:

Articles July 2018

High-Performance Virtual Reality Volume Rendering of Original Optical Coherence Tomography Point-Cloud Data Enhanced With Real-Time Ray Casting

PDF

Peter M Maloca; J. Emanuel Ramos de Carvalho; Tjebo Heeren; Pascal W Hasler; Faisal Mushtaq; Mark Mon-Williams; Hendrik P.N. Scholl; Konstantinos Balaskas; Catherine Egan; Adnan Tufail; Lilian Witthauer; Philippe C. Cattin
TAGS: casts, surgical, software, diagnostic imaging, virtual reality, optical coherence tomography, volume rendering
Trans. Vis. Sci. Tech.. 2018; 7(4):2. doi: 10.1167/tvst.7.4.2

Includes: Multimedia, Supplemental Content

Articles July 2018

Safety and Feasibility of a Novel Sparse Optical Coherence Tomography Device for Patient-Delivered Retina Home Monitoring

PDF

Peter Maloca; Pascal W. Hasler; Daniel Barthelmes; Patrik Arnold; Mooser Matthias; Hendrik P. N. Scholl; Heinrich Gerding; Justus Garweg; Tjebo Heeren; Konstantinos Balaskas; J. Emanuel Ramos de Carvalho; Catherine Egan; Adnan Tufail; Sandrine A. Zweifel
TAGS: safety, eye, retina, optical coherence tomography
Trans. Vis. Sci. Tech.. 2018; 7(4):8. doi: 10.1167/tvst.7.4.8

ARVO Annual Meeting Abstract June 2017

Retinal Layer Location of Increased Retinal Thickness and Retinal Thinning on the cohort of the EUROCONDOR clinical trial

Miguel Ângelo Costa; Luísa Ribeiro; Jose Garcia-Arumi; Peter Scanlon; Jakob Grauslund; Francesco Bandello; Jonathan Gibson; Edoardo Midena; Gabriele Elisabeth Lang; Simon P Harding; Catherine A Egan; Pascale Massin; Torcato Santos; Berta Ponsati; Jose G Cunha-Vaz; Rafael Simó

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):62. doi:

ARVO Annual Meeting Abstract June 2017

Imaging of remnant cone structure in outer retinal lesions in macular telangiectasia (MacTel) type 2

Katie M Litts; Mali Okada; Angelos Kalitzeos; Melissa Kasilian; Rebecca Mastey; Michel Michaelides; Joseph Carroll; Catherine A Egan

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):6007. doi:

ARVO Annual Meeting Abstract June 2017

Clinical Features Predict Diabetic Retinopathy Progression

Cecilia S Lee; Aaron Y Lee; Doug Baughman; Atul Varma; Salim Natha; Louise Downey; Geeta Menon; Sajjad Mahmood; Usha Chakravarthy; David Paul Crabb; Alastair K Denniston; Clare Bailey; Adnan Tufail; Catherine A Egan

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4283. doi:

ARVO Annual Meeting Abstract June 2017

Changes in glycated hemoglobin levels following consultation with diabetes specialist nurse in retinal clinics

Mahmood El-Gasim; Razia Amin; Shehab Al-Abed; adam mapani; Omar Abdul Rahman Mahroo; Declan Flanagan; Catherine A Egan

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):2897. doi:

ARVO Annual Meeting Abstract June 2017

Clinical, optical coherence tomography and fundus autofluorescence findings in atrophic maculopathy associated with pseudoxanthoma elasticum

Panagiotis Vasilopoulos; Andrew R Webster; Catherine A Egan; Hemal Mehta; Philip G Hykin

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4639. doi:

ARVO Annual Meeting Abstract June 2017

Electrophysiological Characterization of Macular Telangiectasia Type 2 (MacTel)

Mali Okada; Anthony G Robson; Catherine A Egan; Ferenc Sallo; Simona Degli Esposti; Tjebo FC Heeren; Graham E Holder

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4886. doi:

ARVO Annual Meeting Abstract June 2017

TOPICAL ADMINISTRATION OF SOMATOSTATIN AND BRIMONIDINE IN THE EARLY STAGES OF DIABETIC RETINOPATHY: RESULTS OF THE EUROCONDOR STUDY

Rafael Simó; Francesco Bandello; Catherine A Egan; Jose Garcia-Arumi; Jonathan Gibson; Jakob Grauslund; Simon P Harding; Gabriele Elisabeth Lang; Pascale Massin; Edoardo Midena; Peter Scanlon; Berta Ponsati; Massimo Porta; Luísa Ribeiro; Cristina Hernández; Jose G Cunha-Vaz

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):5797. doi:

ARVO Annual Meeting Abstract June 2017

Peripapillary Pachychoroid Syndrome

Nopasak Phasukkijwatana; Rosa Dolz-Marco; Mayss Al-Sheikh; Lee M Jampol; Pearse Andrew Keane; Catherine A Egan; Sandeep Randhawa; Jay M Stewart; Qingyun Liu; Alex Paul Hunyor; Allan E Kreiger; Aaron Nagiel; Robert Arthur Lalane; Won Ki Lee; K Bailey Freund; David Sarraf

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):5929. doi:

ARVO Annual Meeting Abstract September 2016

Evaluation of radial peripapillary capillaries in diabetic retinopathy using optical coherence tomography angiography – looking beyond macular ischemia

Maria Gkika; Jibran Mohamed-Noriega; Lei Liu; Pearse A Keane; Catherine A Egan; Adnan Tufail; Dawn Sim

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):5493. doi:

ARVO Annual Meeting Abstract September 2016

Longitudinal analysis of the foveal avascular zone in diabetic retinopathy using optical coherence tomography angiography.

YIJUN CAI; Jibran Mohamed-Noriega; Pearse Andrew Keane; Catherine A Egan; Adnan Tufail; Dawn A Sim

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):5498. doi:

ARVO Annual Meeting Abstract September 2016

Comparisons between an Optometrist (Optom), Trained Diabetic Retinal Screener/Grader (Grader) and Consultant Ophthalmologist (Consultant) assessments of Ultrawide field (UWF) images in Diabetic Retinopathy in a Teleophthalmology Setting.

Jae Jin Lee; Philip Alexander; Hussain Khambati; Mumina Khatun; Pearse A Keane; Catherine A Egan; Dawn Sim

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):6326. doi:

ARVO Annual Meeting Abstract September 2016

Comparison of retinal segmentation analyses among diabetic patients with or without macular ischemia

Rengin Aslihan KURT; Dawn A Sim; Pearse Andrew Keane; Alberto La Mantia; Catherine A Egan; Adnan Tufail

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):6329. doi:

1 2 3 4 5

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Filters

Specify Date Range

Dark-Adapted Two-Color Fundus-Controlled Perimetry in Macular Telangiectasia Type 2

Diabetes mellitus in MacTel Can Diabetes Mellitus be a negative prognosticator in MacTel?

Longitudinal Assessment Of Reading Test Performance In Patients With Type 2 Macular Telangiectasia (MacTel)

Twelve-month longitudinal study of remnant cone structure in macular telangiectasia type 2

Macular photoreceptor atrophy defines the end stage of macular telangiectasia type 2

Human Serum Metabolomics Study in Macular Telangiectasia Type 2

High-Performance Virtual Reality Volume Rendering of Original Optical Coherence Tomography Point-Cloud Data Enhanced With Real-Time Ray Casting

Safety and Feasibility of a Novel Sparse Optical Coherence Tomography Device for Patient-Delivered Retina Home Monitoring

Retinal Layer Location of Increased Retinal Thickness and Retinal Thinning on the cohort of the EUROCONDOR clinical trial

Imaging of remnant cone structure in outer retinal lesions in macular telangiectasia (MacTel) type 2

Clinical Features Predict Diabetic Retinopathy Progression

Changes in glycated hemoglobin levels following consultation with diabetes specialist nurse in retinal clinics

Clinical, optical coherence tomography and fundus autofluorescence findings in atrophic maculopathy associated with pseudoxanthoma elasticum

Electrophysiological Characterization of Macular Telangiectasia Type 2 (MacTel)

TOPICAL ADMINISTRATION OF SOMATOSTATIN AND BRIMONIDINE IN THE EARLY STAGES OF DIABETIC RETINOPATHY: RESULTS OF THE EUROCONDOR STUDY

Peripapillary Pachychoroid Syndrome

Evaluation of radial peripapillary capillaries in diabetic retinopathy using optical coherence tomography angiography – looking beyond macular ischemia

Longitudinal analysis of the foveal avascular zone in diabetic retinopathy using optical coherence tomography angiography.

Comparisons between an Optometrist (Optom), Trained Diabetic Retinal Screener/Grader (Grader) and Consultant Ophthalmologist (Consultant) assessments of Ultrawide field (UWF) images in Diabetic Retinopathy in a Teleophthalmology Setting.

Comparison of retinal segmentation analyses among diabetic patients with or without macular ischemia

To View More...

You must be signed into an individual account to use this feature.